Research ArticlePEDIATRICS
MR Imaging and Proton MR Spectroscopic Studies in Sjögren-Larsson Syndrome: Characterization of the Leukoencephalopathy
Michèl A. A. P. Willemsen, Marinette van der Graaf, Marjo S. van der Knaap, Arend Heerschap, Peter H. M. F. van Domburg, Fons J. M. Gabreëls and Jan J. Rotteveel
American Journal of Neuroradiology April 2004, 25 (4) 649-657;
Michèl A. A. P. Willemsen
Marinette van der Graaf
Marjo S. van der Knaap
Arend Heerschap
Peter H. M. F. van Domburg
Fons J. M. Gabreëls
References
- ↵Sjögren T, Larsson T. Oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta Psych Neurol Scand 1957;32 suppl(113):1–113
- ↵Jagell S, Gustavson KH, Holmgren G. Sjögren-Larsson syndrome in Sweden: a clinical, genetic and epidemiological study. Clin Genet 1981;19:233–256
- ↵Van Domburg PHMF, Willemsen MAAP, Rotteveel JJ, et al. Sjögren-Larsson syndrome: clinical and MRI/MRS spectroscopy findings in FALDH deficient patients. Neurology 1999;52:1345–1352
- Willemsen MAAP, Cruysberg JRM, Rotteveel JJ, Aandekerk AL, van Domburg PHMF, Deutman AF. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome. Am J Ophthalmol 2000;130:782–789
- ↵Willemsen MAAP, IJlst L, Steijlen PM, et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome. Brain 2001;124:1426–1437
- ↵Rizzo WB. Sjögren-Larsson syndrome: fatty aldehyde dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill;2001 :2239–2258
- ↵Rizzo WB, Craft DA. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts. J Clin Invest 1991;88:1643–1648
- ↵Kelson TL, Secor McVoy JR, Rizzo WB. Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization. Biochim Biophys Acta 1997;1335:99–110
- ↵James PF, Zoeller RA. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff’s base modification of phospholipids: implications for Sjögren-Larsson syndrome. J Biol Chem 1997;272:23532–23539
- ↵Verhoeven NM, Jakobs C, Carney G, Somers MP, Wanders RJA, Rizzo WB. Involvement of microsomal fatty aldehyde dehydrogenase in the α-oxidation of phytanic acid. FEBS Lett 1998;429:225–228
- ↵Rizzo WB, Craft DA. Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma. J Lipid Res 2000;41:1077–1081
- Rizzo WB, Heinz E, Simon M, Craft DA. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome. Biochim Biophys Acta 2000;1535:1–9
- ↵Willemsen MAAP, Rotteveel JJ, de Jong JGN, et al. Defective metabolism of leukotriene B4 in the Sjögren-Larsson Syndrome. J Neurol Sci 2001;183:61–67
- ↵Di Rocco M, Filocamo M, Tortori-Donati P, Veneselli E, Borrone C, Rizzo WB. Sjögren-Larsson syndrome: nuclear magnetic resonance imaging of the brain in a 4-year-old boy. J Inher Metab Dis 1994;17:112–114
- ↵Miyanomae Y, Ochi M, Yoshioka H, et al. Cerebral MR imaging and spectroscopy in Sjögren-Larsson syndrome: case report. Neuroradiology 1995;37:225–228
- Hussain MZ, Aihara M, Oba H, et al. MR imaging of white matter changes in the Sjögren-Larsson syndrome. Neuroradiology 1995;37:576–577
- ↵Phanthumchinda K, Srimanuthipol K, Yodnophaklao P. Sjögren-Larsson syndrome. J Med Assoc Thai 1996;79:541–544
- ↵Van Mieghem F, van Goethem JWM, Parizel PM, et al. MR of the brain in Sjögren-Larsson syndrome. AJNR Am J Neuroradiol 1997;18:1561–1563
- ↵Mano T, Ono J, Kaminaga T, et al. Proton MR spectroscopy of Sjogren-Larsson’s syndrome. AJNR Am J Neuroradiol 1999;20:1671–1673
- ↵Altinok D, Yildiz YT, Seckin D, Altinok G, Tacal T, Eryilmaz M. MR imaging of three siblings with Sjogren-Larsson syndrome. Pediatr Radiol 1999;29:766–769
- ↵Bredmose GV. Et tilfaelde af mongoloid idioti og ichthyosis med neurohistologiske forandringer. Nord Med 1940;5:440–442
- ↵Baar HS, Galindo J. Pathology of the Sjogren-Larsson syndrome. J Maine Med Assoc 1965;56:223–226
- ↵Sylvester PE. Pathological findings in Sjögren-Larsson syndrome. J Ment Defic Res 1969;13:267–275
- ↵Silva CA, Saraiva A, Goncalves V, de Sousa G, Martins R, Cruz C. Pathological findings in one of two siblings with Sjögren-Larsson syndrome. Eur Neurol 1980;19:166–170
- ↵Wester P, Bergstrom U, Brun A, Jagell S, Karlsson B, Eriksson A. Monoaminergic dysfunction in Sjogren-Larsson syndrome. Mol Chem Neuropathol 1991;15:13–28
- ↵Yamamoto T, Sekiya T, Sekine Y, Konishi E, Aoyama M, Takashima H. An autopsy case of Sjögren-Larsson syndrome with mental deficiency, ichthyosis, spastic diplegia and generalized hyperaminoaciduria. Adv Neurol Sci 1971;15:731–744
- ↵McLennan JE, Gilles FH, Robb RM. Neuropathological correlation in Sjögren-Larsson syndrome: oligophrenia, ichthyosis and spasticity. Brain 1974;97:693–708
- ↵Yamaguchi K, Handa T. Sjögren-Larsson syndrome: postmortem brain abnormalities. Pediatr Neurol 1998;18:338–341
- ↵Barkovich AJ, Kjos BO, Jackson DE, Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Neuroradiology 1988;166:173–180
- ↵Van der Knaap MS, Valk J. MR imaging of the various stages of myelination during the first year of life. Neuroradiology 1990;31:459–470
- ↵Gadian DG. NMR and its applications to living systems. Oxford: Oxford University Press;1995 :267–269
- ↵Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–679
- ↵Sylvain M, Arnold DL, Scriver CR, Schreiber R, Shevell MI. Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 1994;10:228–232
- ↵Viola A, Confort-Gouny S, Ranjeva JP, et al. MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 2002;23:480–483
- ↵Rizzo WB. Inherited disorders of fatty alcohol metabolism. Mol Genet Metab 1998;65:63–73
- ↵Wolinsky JS, Narayana PA, Fenstermacher MJ. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 1990;40:1764–1769
- ↵Bruhn H, Kruse B, Korenke GC, et al. Proton NMR spectroscopy of cerebral alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 1992;16:335–344
- ↵Tzika AA, Ball WS, Vigneron DB, Dunn RS, Kirks DR. Clinical proton MR spectroscopy of neurodegenerative disease in childhood. AJNR Am J Neuroradiol 1993;14:1267–1281
- ↵Jagell S. SLS or not SLS: Sjogren-Larsson syndrome. Pediatr Neurol 1998;19:399
- ↵Willemsen MA, Lutt MA, Steijlen PM, et al. Clinical and biochemical effects of zileuton in patients with the Sjogren-Larsson syndrome. Eur J Pediatr 2001;160:711–717
In this issue
Advertisement
MR Imaging and Proton MR Spectroscopic Studies in Sjögren-Larsson Syndrome: Characterization of the Leukoencephalopathy
Michèl A. A. P. Willemsen, Marinette van der Graaf, Marjo S. van der Knaap, Arend Heerschap, Peter H. M. F. van Domburg, Fons J. M. Gabreëls, Jan J. Rotteveel
American Journal of Neuroradiology Apr 2004, 25 (4) 649-657;
MR Imaging and Proton MR Spectroscopic Studies in Sjögren-Larsson Syndrome: Characterization of the Leukoencephalopathy
Michèl A. A. P. Willemsen, Marinette van der Graaf, Marjo S. van der Knaap, Arend Heerschap, Peter H. M. F. van Domburg, Fons J. M. Gabreëls, Jan J. Rotteveel
American Journal of Neuroradiology Apr 2004, 25 (4) 649-657;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Child Neurology: Sjögren-Larsson syndrome
- Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system
- Magnetic resonance spectroscopy of the brain
- Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models
- MR Spectroscopy Detects Lipid Peaks in Cerebrotendinous Xanthomatosis
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement